Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Are UK companies being taken over on the cheap?

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
On 29 June private equity firm Clayton, Dubilier & Rice increased its offer for pharmaceutical firm UDG Healthcare (UDG) by 5.5% to £10.80, valuing the company at £2.93 billion, including debts.
The new higher price represents a premium of 28.3% to the pre-bid closing price on 11 May 2021 which is below the average 36% premia offered across almost 50 takeovers since last October according to data collected by Russ Mould, investment director at AJ Bell.
The private equity firm had already obtained approval from UDG’s board at a lower price, but its largest shareholder Allianz Global Investors, together with other top shareholders, criticised the board for accepting a price they considered to undervalue the company.
Institutional shareholders are increasingly pushing back against private equity takeovers, asking for more in the belief that private equity buyers are picking up UK companies on the cheap.
In all-cash offers the selling shareholders are forgoing the upside of future value creation and therefore need to be compensated appropriately.
Institutional shareholders have a responsibility to their customers to ensure they receive a price as close to fair value as possible.
It’s hard to believe that UDG’s leading shareholders had such a stingy 5.5% increase in mind when they were in discussions with the private equity group, but unless a rival bid materialises the latest deal looks like it will be enough to secure the prize.
Shares magazine is owned by AJ Bell. Daniel Coatsworth who edited this article owns shares in AJ Bell.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.
Our website uses cookies to give you a better browsing experience.
You can choose to accept all cookies, or control which we use by clicking 'Manage cookies'. To learn more, read our cookie policy.